Pharmaceutical
Business Unit started its development in
Prostaglandin derivatives and has successfully
commercialized several active pharmaceutical
ingredients (API’s) with DMF, EDMF submission to
US FDA and EDQM.
In addition, our Felodipine API for Cardiovascular
application also plays a role in assisting our
clients to secure their global market shares.
Everlight’s US FDA inspected production facility
has implemented the cGMP system in conformity with
the universal ICH guidance.